Perseris

Active Ingredient(s): Risperidone
FDA Approved: * July 27, 2018
Pharm Company: * INDIVIOR INC
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Perseris Overview

Risperidone, sold under the trade name Risperdal among others, is an antipsychotic medication.[2] It is mainly used to treat schizophrenia, bipolar disorder, and irritability in people with autism.[2] It is taken either by mouth or by injection into a muscle.[2] The injectable version is long acting and lasts for about two weeks.[3] Common side effects include movement problems, sleepiness, trouble seeing, constipation, and incre...

Read more Perseris Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Risperidone

Recent Perseris Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Risperidone
  • For Suspension, Extended Release: 120mg, 90mg
  • Injection: 12.5mg/vial, 120mg, 25mg, 25mg/vial, 37.5mg, 37.5mg/vial, 50mg, 50mg/vial, 90mg
  • Solution: 1mg/ml
  • Tablet: 0.05mg, 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg, 5mg
  • Tablet, Orally Disintegrated: 1mg, 2mg
  • Tablet, Orally Disintegrating: 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Risperidone or a similar ingredient: (4 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 November 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA